Hybridoma Development Studies and Antibody Production

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ARMY MED RES ACQ ACTIVITY

Contract Value

Not provided

Codes & Classification
Solicitation Number

HT942525R0009

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Classification Code

6505

Additional Details
Set Aside

SBA

Place of Performance

-

SourceSAM
The United States Army Medical Research Acquisition Activity (USAMRAA) has issued a solicitation (Procurement Identifier: HT942525R0009) for severable, non-personal services to support hybridoma development studies and antibody production. This procurement is intended to advance the research objectives of the Division of Virology at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), which specializes in molecular virology, cell biology, immunology, viral virulence factor determination, and viral strain diversity characterization. The scope of this contract encompasses the development of hybridomas and the subsequent production of antibodies, which are critical tools for the Division’s ongoing research into viral pathogens and their biological mechanisms. The contractor will be expected to provide comprehensive laboratory services that facilitate the generation and characterization of monoclonal antibodies, supporting USAMRIID’s mission to understand and counteract infectious diseases. Key requirements for this opportunity include demonstrated expertise in biological product manufacturing, specifically in the area of hybridoma technology and antibody production. The successful contractor must be capable of delivering high-quality, reproducible results that meet the rigorous standards of federal biomedical research. Deliverables will likely include the generation of hybridoma cell lines, production and purification of monoclonal antibodies, and detailed documentation of methodologies and results, although specific deliverables should be confirmed by reviewing the full solicitation. This procurement is classified under NAICS Code 325414 (Biological Product (except Diagnostic) Manufacturing), with Product Service Code 6505, indicating a focus on pharmaceutical and biological products. The solicitation is set aside for Small Business Administration (SBA) eligible entities, providing an opportunity for qualified small businesses to participate in federal biomedical research support. The contracting entity is the Army Medical Research Acquisition Activity, a federal office responsible for supporting the research needs of USAMRIID. Interested parties should direct inquiries to the designated contacts: Shelley Wallace ([email protected], 301-619-1352) and Emily OHara ([email protected], 301-619-9599). The solicitation was posted on December 19, 2024, and responses are due by December 31, 2024, at 17:12. The notice remains active and can be accessed via SAM.gov at https://sam.gov/opp/7a41ab60042647e8a27c3d378c307f48/view. Contractors considering this opportunity should ensure their capabilities align with the requirements for hybridoma development and antibody production, and that they meet the SBA set-aside criteria. The contract will support critical research activities that are central to USAMRIID’s mission and will require consistent, high-quality scientific deliverables throughout its lifecycle.